Noida ophthalmologist warns ‘eye drops are not a solution’; shares 4 things you must know to protect your eyes for life

Ophthalmologist Dr Chetan warns against sleeping with contact lenses and using eye drops without prescription; highlights proper eye care to avoid vision loss.

Fancy dress contact lenses can cause infections, ulcers and even blindness. Here’s how to keep your eyes safe this Halloween

Around Halloween, fancy dress contact lenses can be found everywhere. This makes it easy for anyone to purchase them without ...

Experts warn Halloween fancy dress accessory can cause blindness

The quality of the materials is an especially important factor here. Studies have found unauthorised dyes and other ...

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activit…

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
Sportschosun on MSN

Changing the color of your eyes during pregnancy. Children also have blue eyes. This is why netizens...

A young woman in Russia caused controversy on social media by saying that she had a procedure to change the color of her eyes during pregnancy and that her child would inherit the color of her eyes.

NanoViricides Dual Track Clinical Strategy Explained by a Research Report – Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Le Lézard

PADCEVtm Plus KEYTRUDAtm, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

Johnson & Johnson: Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...